Drug intelligence / Profile preview

3-nitropropionic acid

Development stage
Discontinued
Modality
Small Molecules
Administration
Experimental (commonly Systemic Injection Or Oral, Preclinical Use Only)
01

Overview

3-nitropropionic acid is a naturally occurring mycotoxin and potent neurotoxic nitroalkane that acts as an **irreversible inhibitor of succinate dehydrogenase** (complex II) in the mitochondrial electron transport chain, leading to mitochondrial dysfunction and neurotoxicity[1][2][5][6][7]. It is produced by certain fungi (notably of the genus Arthrinium), can contaminate foods such as sugar cane, miso, soy sauce, katsuobushi, coconuts, and some traditional Chinese medicines[1][3][7]. In preclinical research it is widely used to induce models of Huntington's disease and other forms of neurodegeneration by causing striatal injury and chemical hypoxia in laboratory animals[5][3][7]. It is not an approved pharmaceutical and is toxic to humans.

Other names
β-nitropropionic acidbeta-nitropropionic acid3-NPAbovinocidin3-NP acidnci-c03076nci-c-03076nci-c 03076hiptagenicacid3-nitropropanoate3-nitropropanoicacinitro-propanoic acid3-nitro-propionicaci
02

Targets

SDH (Mitochondrial electron transport chain complex II)

Beyond the preview

Go deeper on 3-nitropropionic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-nitropropionic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call